Archive for October 10th, 2008

Chemical Market Reporter - Baxter acquires majority of ESI Lederle. (Breaking News Roundup).(Baxter Healthcare)(Brief Article)

Friday, October 10th, 2008

Baxter Healthcare Corp. has agreed to acquire a majority of ESI Lederle, a division of Wyeth, for $305 million. Baxter gains a 330,000 square foot facility at Cherry Hill, N.J., for manufacturing injectable small-volume drugs, and 1,000 new employees. Generic injectable products and patent-expired branded products under the deal include Phenergan (promethazine), Ativan …

Most Popular
5 Regular Mistakes In Public Speaking
13 Job Interview Mistakes …